A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies

Clinical trial NCT06820268 · RECRUITING

Trial details

NCT number: NCT06820268
Sponsor: NovaOnco Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Lymphoma Acute Myeloid Leukemia Myelodysplastic Syndrome

Start date: 2025-01-14
Primary completion: 2027-11-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.